Prelude Therapeutics Incorporated Profile Avatar - Palmy Investing

Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select sol…

Biotechnology
US, Wilmington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Prelude Therapeutics Incorporated mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PRLD's Analysis
CIK: 1678660 CUSIP: 74065P101 ISIN: US74065P1012 LEI: - UEI: -
Secondary Listings
PRLD has no secondary listings inside our databases.